🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,867 results for “De” Clear

  1. Evrysdi 0.75 mg/mL powder for oral solution, RO7034067

    Hoffmann-La Roche

    Spinal Muscular Atrophy (SMA)

    approved small molecule active

    1 trial

  2. Exenatide

    The First People's Hospital of Lianyungang

    Type 2 Diabetes

    approved small molecule active

    1 trial

  3. Exenatide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  4. Exparel

    Pacira Ireland Limited

    Ankle Arthrodesis

    approved small molecule completed

    1 trial

  5. Experimental 23-valent PPV

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    1 trial

  6. Experimental 23-valent Pneumococcal

    Sinovac Research and Development Co.,

    Pneumococcal Infections

    approved mab completed

    1 trial

  7. Experimental Group

    Sinovac Research and Development Co.,

    COVID-19

    approved mab completed

    4 trials

  8. Experimental Vaccine

    Sinovac Research and Development Co.,

    Hand, Foot and Mouth Disease

    approved mab active

    1 trial

  9. Experimental vaccine 1

    Sinovac Research and Development Co.,

    COVID-19

    approved mab on hold

    1 trial

  10. Extended-Release Buprenorphine (XRB)

    BRIGHT MINDS BIOSCIENCES INC.

    Opioid Use Disorder

    approved small molecule active

    1 trial

  11. Extended-Release Naltrexone

    BRIGHT MINDS BIOSCIENCES INC.

    Heroin Dependence

    approved small molecule completed

    1 trial

  12. Eylea (Intravitreal Aflibercept, VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Macular Degeneration

    approved small molecule completed

    1 trial

  13. Eylea 114.3 mg/ml solution for injection

    Bayer AG

    Neovascular age-related macular degeneration (nAMD), Diabetic macular edema (DME)

    approved small molecule active

    1 trial

  14. Fentanyl hameln 50 microgram/ml, oplossing voor injectie, Narcan Nasal Spray, Sufentanil Eurocept 5 microgram/ml, oplossing voor injectie, Zofran 4 Injectie, Naloxon HCl-hameln 0,4 mg/ml, oplossing voor injectie/infusie

    Disc Medicine

    healthy volunteers, opioid use disorder

    approved small molecule active

    1 trial

  15. Feraccru 30 mg hard capsules

    Lacuna Pharma Pty Ltd

    iron deficient

    approved small molecule active

    1 trial

  16. Ferinject

    Disc Medicine

    Patients with Aortic stenosis and Iron deficiency

    approved small molecule active

    1 trial

  17. Ferric derisomaltose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Heart Failure With Reduced Ejection Fraction

    approved small molecule active

    1 trial

  18. Ferric derisomaltose

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Heart Failure With Preserved Ejection Fraction

    approved small molecule active

    1 trial

  19. Fespixon Cream

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Foot Ulcer (DFU)

    approved small molecule terminated

    1 trial

  20. Fluconazol Accord 50 mg capsules, hard, Diflucan I.V. 2 mg/ml, oplossing voor infusie, Diflucan 100 mg, capsule, hard, Diflucan 10 mg/ml, poeder voor orale suspensie

    Disc Medicine

    Fungal infection

    approved small molecule active

    1 trial

  21. Fludesoxiglucosa (18F)-Curium 185 MBq/ml, solución inyectable

    The George Institute

    Cardiovascular device infections

    approved small molecule active

    1 trial

  22. Fludex 1,5 mg, επικαλυμμένα με λεπτό υμένιο δισκία παρατεταμένης αποδέσμευσης., LUCIDEL 150 mg επικαλυμμένα με λεπτό υμένιο δισκία., Amlopen® 5mg καψάκια σκληρά, Inosamin 25mg, επικαλυμμένα με λεπτό υμένιο δισκία

    The George Institute

    Hypertension

    approved small molecule active

    1 trial

  23. Fluocinolone Acetonide Intravitreal Implant 0.18 mg

    ANI PHARMACEUTICALS INC

    Uveitis, Posterior

    approved small molecule active

    1 trial

  24. Fluoxetine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Depressive Disorder

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources